Intended Use

The CardioLogs ECG Analysis Platform is intended for use by qualified healthcare professionals for the assessment of arrhythmias using ECG data in subjects over 18 years of age, supporting data from Holter, event recorders, 12 lead ambulatory ECG devices, and other similar devices.

Technology

The platform consists of a cloud-based application (Platform as a Service) and a client-side web application. It performs ECG signal processing, feature extraction (P waves, QRS complexes, T waves), multi-label classification of abnormalities, and provides an interface for users to review and edit results. It supports manual or automatic ECG data upload via an API and stores data securely.

Performance

Performance testing included verification and validation against design inputs and clinical gold standards, usability testing, and compliance with multiple recognized consensus standards such as AAMI ANSI IEC 62304 and IEC 60601-2-25. Testing showed no anomalies and met all requirements for safety and effectiveness.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    2/27/2017

    3 months
  • 2

    FDA Approval

    6/26/2017

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.